Pharmacy stocks got a lift in trading Monday after CNBC reported Amazon is backing off of selling drugs to hospitals.
With volatility back and valuations stretched, Fidelity fund managers are focused on stocks that are of a high quality, properly valued and pay dividends.
Critics indicate that the pharmacy chain could do a better job revamping its stores on its own.
Analysts recommend buying shares of companies with large domestic sales exposure.
Protectionist move: if a global trade war erupts, domestic-facing U.S. stocks should fare well.
The move could spur a price war, pressuring margins at rivals CVS, Walgreens and Rite Aid.
Albertson and Rite Aid are inking a deal in an effort to push back the likes of Amazon and Walmart.
Billionaires investors like Ray Dalio and Larry Robbins were bullish on Walgreens in Q4, 13F filings indicate.
Bridgewater Associates, the firm of hedge fund billionaire Ray Dalio, took large positions in ETFs, 13F filings show.
The threat of an integrated pharmacy could spur consolidation in a disrupted health care space.